This image is not available for purchase in your country.

Sofosbuvir hepatitis C drug

Sofosbuvir hepatitis C drug

C022/8829

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY RAMON ANDRADE 3DCIENCIA / SCIENCE PHOTO LIBRARY

Caption

Sofosbuvir hepatitis C drug, molecular model. This antiviral drug, marketed as Sovaldi, is used to treat chronic hepatitis C infections. It works by inhibiting the enzyme RNA polymerase that the virus uses to replicate its RNA (ribonucleic acid) genome. The hepatitis C virus infects liver cells causing an inflammatory disease that can lead to degeneration and scarring (cirrhosis). When used in combination with the drug Ledipasvir, sofosbuvir cures 90 per cent of patients.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}